GEA Niro has extended its offerings to include contract manufacturing on extensive cGMP spray drying facilities. The GEA Niro Pharma Test Station is available for developing spray drying processes for pharmaceuticals and pharmaceutical grade products and for production of samples for safety, stability and toxicology studies and of Clinical Trials Materials.
Michael Wahlberg, head of GEA Niro’s Test & Development. ‘Spray drying is currently being explored widely in the pharmaceutical industry, and we offer to assist and put our expertise at the industry’s disposal, ‘Working with us allows clients to work with spray drying and achieve proof of concept fast and effectively. The processes for effective drug delivery can be developed before any major capital investments are made’.
The GEA Niro Pharma Test Station is a fully equipped cGMP spray drying facility. It includes two GEA Niro PHARMASDTM spray dryers; a PSD-1 spray dryer, which is a laboratory size unit suitable for initial tests and productions of small quantities and a PSD-4 spray dryer for full-scale produc-tions. The Pharma Test Station is part of GEA Niro’s Test Center where spray drying process de-velopment and initial tests can be performed under flexible non-GMP conditions before being burdened by cGMP requirements.